Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05404321
What this trial is testing

Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment

Who this might be right for
Triple Negative Breast CancerOrganoid
Centre Francois Baclesse 163
Testing effectiveness (Phase 2)Active Not RecruitingNCT03971409
What this trial is testing

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

Who this might be right for
Stage III Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+6 more
Laura Huppert, MD, BA 145
Testing effectiveness (Phase 2)Ended earlyNCT04441099
What this trial is testing

NBE-002 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerTriple Negative Breast Cancer
NBE-Therapeutics AG 12
Testing effectiveness (Phase 2)Looking for participantsNCT06793332
What this trial is testing

BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC

Who this might be right for
Triple-Negative Breast Cancer (TNBC)Brain Metastases
Fudan University 39
Testing effectiveness (Phase 2)WithdrawnNCT01015521
What this trial is testing

Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer

Who this might be right for
Breast Neoplasm
Tigris Pharmaceuticals 50
Testing effectiveness (Phase 2)UnknownNCT02934828
What this trial is testing

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 230
Early research (Phase 1)Active Not RecruitingNCT03945721
What this trial is testing

A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast CancerResidual Disease
Massachusetts General Hospital 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07581314
What this trial is testing

Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple-Negative Breast Cancer (TNBC)Advanced Triple-Negative Breast CancerMetastatic Triple-negative Breast Cancer
Telomir Pharmaceuticals, Inc. 76
Early research (Phase 1)Ended earlyNCT01238133
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+6 more
National Cancer Institute (NCI) 14
Early research (Phase 1)Looking for participantsNCT04282044
What this trial is testing

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more
BioEclipse Therapeutics 60
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698106
What this trial is testing

Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
University Health Network, Toronto 60
Early research (Phase 1)Study completedNCT01650506
What this trial is testing

Study of Erlotinib and Metformin in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Columbia University 8
Testing effectiveness (Phase 2)WithdrawnNCT03175666
What this trial is testing

QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy

Who this might be right for
Triple Negative Breast Cancer
ImmunityBio, Inc.
Early research (Phase 1)Study completedNCT03243331
What this trial is testing

An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerMetastatic Breast Cancer
Kathy Miller 18
Testing effectiveness (Phase 2)Looking for participantsNCT05485766
What this trial is testing

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast NeoplasmsTriple Negative Breast CancerBreast Neoplasms+5 more
Okayama University 23
Testing effectiveness (Phase 2)UnknownNCT05266937
What this trial is testing

Atezolizumab Plus CArboplatin Plus Nab-paclitaxel

Who this might be right for
Metastatic Breast CancerTriple Negative Breast CancerPD-L1 Gene Mutation
Consorzio Oncotech 49
Testing effectiveness (Phase 2)Ended earlyNCT02202746
What this trial is testing

Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastatic Breast CancerMBC+5 more
Clovis Oncology, Inc. 178
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Not applicableActive Not RecruitingNCT07092254
What this trial is testing

Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Daiichi Sankyo 760
Next Page